Uddin, Shahab <br/><br/>
Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer.  [electronic resource] 

 -  Laboratory investigation; a journal of technical methods and pathology  Oct 2009 
 - 1115-27 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1530-0307 
<br/><br/><label>Standard No.: </label>10.1038/labinvest.2009.75  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Carcinoma--drug therapy<br/>Caspases--metabolism<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cisplatin--therapeutic use<br/>Cyclin-Dependent Kinase Inhibitor p27<br/>Down-Regulation<br/>Enzyme Activation--drug effects<br/>Female<br/>Gene Expression Profiling<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--metabolism<br/>Mice<br/>Mice, Nude<br/>Mitochondria--drug effects<br/>Oligonucleotide Array Sequence Analysis<br/>Ovarian Neoplasms--drug therapy<br/>Proteasome Inhibitors<br/>Pyrazines--pharmacology<br/>S-Phase Kinase-Associated Proteins--metabolism<br/>Tissue Array Analysis<br/>Transplantation, Heterologous<br/>Up-Regulation